Molecular Pathology, Diagnostics, and Therapeutics

Special Issues

Following special issues within this section are currently open for submissions:

• Molecular Pathogenesis of Oral Potentially Malignant Disorders Transformation (Deadline: 10 October 2023)
• Rising of New Signatures in Skeletal Muscle Pathologies and Their Possible Role in Disease Pathogenesis (Deadline: 15 October 2023)
• Molecular Advances in Infectious Disease (Deadline: 15 October 2023)
• Photodynamic Therapy: Outlook and Future Direction (Deadline: 15 October 2023)
• Chronic Hypoxia and Inflammation in Human Pathology (Deadline: 15 October 2023)
• Understanding Parkinson's Disease (Deadline: 15 October 2023)
• Musculoskeletal Development and Skeletal Pathophysiologies 2.0 (Deadline: 15 October 2023)
• Frontiers on Induced Pluripotent Stem Cells (iPSCs) (Deadline: 15 October 2023)
• Recent Advances in Molecular Pathophysiology of Cardiovascular Diseases (Deadline: 15 October 2023)
• Mesenchymal Stem Cells Differentiation in Health and Disease (Deadline: 15 October 2023)
• Towards Personalized Treatment and Molecular Research on Colorectal Cancer (Deadline: 15 October 2023)
• The Role and Characterization of Neutrophils in Human Diseases (Deadline: 15 October 2023)
• Pathophysiology and Therapy of Bladder Function Disorders and Cystitis (Deadline: 15 October 2023)
• Neural Stem Cells: Focusing on Disease Modeling and Translational Application (Deadline: 15 October 2023)
• Pathogenesis and New Therapeutic Approaches for Fibrosing Diseases—the Skin as a Model System (Deadline: 15 October 2023)
• Molecular Insights in Heart Failure (Deadline: 15 October 2023)
• Molecular Mechanisms of Brain Aging and Alzheimer’s Disease (Deadline: 15 October 2023)
• New Insights into Glioblastoma: Cellular and Molecular (Deadline: 20 October 2023)
• Cardiovascular Diseases: Molecular Mechanisms and Potential Therapy (Deadline: 20 October 2023)
• Recent Advances in Drug Discovery (Deadline: 20 October 2023)
• Novel Approaches to Potential COVID-19 Molecular Therapeutics (Deadline: 20 October 2023)
• Penile Carcinoma and Other Male Genitourinary Tumors: Molecular and Cellular Mechanism (Deadline: 22 October 2023)
• Molecular Mechanism of Ovarian Cancer Initiation and Progression (Deadline: 25 October 2023)
• New Trends in Diabetes, Hypertension and Cardiovascular Diseases (Deadline: 25 October 2023)
• The Molecular Mechanisms and Therapeutic Targets of Atherosclerosis (Deadline: 30 October 2023)
• Advanced Molecular Mechanisms and Technologies in Cardiac Regeneration (Deadline: 30 October 2023)
• From Molecular Mechanism to Therapy in Autism Spectrum Disorder (Deadline: 30 October 2023)
• Genetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors 2.0 (Deadline: 30 October 2023)
• Molecular Research on Platelet Activity in Health and Disease 2023 (Deadline: 30 October 2023)
• Synaptic Plasticity and Diseases 2.0 (Deadline: 30 October 2023)
• Astrocyte-Endothelial Interactions at the Blood-Brain Barrier (Deadline: 30 October 2023)
• Molecular and Translational Research on Bone Tumors 2.0 (Deadline: 30 October 2023)
• Protein Kinase in Disease (Deadline: 31 October 2023)
• Gut and the Liver in Health and Disease 2.0 (Deadline: 31 October 2023)
• Molecular Pathophysiology of Uterine and Ovarian Diseases and Dysfunction 4.0 (Deadline: 31 October 2023)
• Advanced Therapies for Parkinson’s Disease (Deadline: 31 October 2023)
• Molecular Mechanisms, Pathogenesis, and Novel Therapeutic Strategies in Cardiovascular Disease (Deadline: 31 October 2023)
• Advances in the Prevention and Treatment of Ischemic Diseases (Deadline: 31 October 2023)
• Roles of Extracellular Vesicles in Cerebrovascular Diseases (Deadline: 31 October 2023)
• Advance Research about Ocular Surface in Ophthalmology (Deadline: 31 October 2023)
• The Interaction between Sleep Disorders and Mental Diseases (Deadline: 31 October 2023)
• Cancer Stem Cells in Solid Tumors (Deadline: 31 October 2023)
• Molecular Mechanisms Associated to Systemic Lupus Erythematosus (Deadline: 31 October 2023)
• RNA Metabolism: Role in Human Pathophysiology and Its Potential for Therapeutic Interventions (Deadline: 31 October 2023)
• The Role of MicroRNAs in Neuronal Development and Disease: Insights into Neurogenesis and Pathogenesis (Deadline: 31 October 2023)
• Molecular Mechanisms of Viral Infection in Pregnancy (Deadline: 31 October 2023)
• Sleep Apnea and Intermittent Hypoxia 4.0 (Deadline: 31 October 2023)
• Extracellular Matrix in Development and Disease 4.0 (Deadline: 31 October 2023)
• New Therapeutic Approaches for Cerebrovascular Diseases Using Genetic and Nanomolecular Tools (Deadline: 31 October 2023)
• Pathogenesis of Pregnancy-Related Complication 2023 (Deadline: 31 October 2023)
• Technological and Molecular Advances in Systemic Lupus Erythematosus (Deadline: 31 October 2023)
• Skeletal Muscle Function and Metabolism: Molecular Mechanisms and Treatment (Deadline: 31 October 2023)
• Molecular Advances in Ovarian Cancer (Deadline: 31 October 2023)
• Nuclear Receptors in Health and Diseases 2.0 (Deadline: 31 October 2023)
• cAMP Signaling: Function and Implication in Diseases (Deadline: 31 October 2023)
• Eosinophilic Esophagitis: Molecular Mechanisms, Diagnosis, and Therapeutic Strategies (Deadline: 31 October 2023)
• Advances in Bone Marrow Microenvironment in Hematological Malignancies (Deadline: 31 October 2023)
• Vitamins in Human Health and Disease: Molecular Mechanisms and Biological Function (Deadline: 31 October 2023)
• Molecular Research in Female Reproductive Disorders (Deadline: 31 October 2023)
• Molecular Pathology Research on Pregnant Uterus, Uterine Infections and Diseases (Deadline: 31 October 2023)
• Epigenetic Mechanisms and Human Pathology 4.0 (Deadline: 31 October 2023)
• Biomarkers in Rare Diseases 3.0 (Deadline: 31 October 2023)
• Updates on Prostate Cancer Research: Molecular Diagnostic Biomarker (Deadline: 31 October 2023)
• A Commemorative Issue in Honour of Rudolf Virchow: From Cell Morphology to Molecular Pathology-Volume 2 (Deadline: 31 October 2023)
• Molecular Research of Regulation of Red Blood Cells in Health, Hereditary or Acquired Diseases (Deadline: 31 October 2023)
• Molecular Research in Breast Cancer: Pathophysiology and Treatment (Deadline: 31 October 2023)
• Endometriosis and Endometriosis-Associated Cancer: Molecular Pathologies, Diagnosis and Therapeutic Strategies (Deadline: 31 October 2023)
• Molecular Advances in Lung Diseases 2.0 (Deadline: 31 October 2023)
• Molecular Research of Osteosarcoma Pathology and the Latest Therapies (Deadline: 31 October 2023)
• Advanced Molecular Science in Immunotherapy (Deadline: 31 October 2023)
• Melanoma: From Molecular Pathology to Therapeutic Approaches (Deadline: 31 October 2023)
• Novel Development and Therapy in Neovascular Retinal Diseases (Deadline: 31 October 2023)
• New Perspective in the Molecular Pathways Involved in Acute and Chronic Lung Injury (Deadline: 31 October 2023)
• Cardiovascular Endocrinology Research (Deadline: 31 October 2023)
• Precision Medicine and New Trends of Molecular Sciences in Vascular Disease (Deadline: 31 October 2023)
• From Bench to Bedside: Well-Established and Emerging Preclinical Models in Cardiovascular Research (Deadline: 31 October 2023)
• Wound Repair and Regeneration 2023 (Deadline: 31 October 2023)
• Recent Advances in Olfactory Genetic Variation and Olfactory Disorders (Deadline: 31 October 2023)
• Rheumatoid Arthritis: Pathogenesis and Treatments (Deadline: 31 October 2023)
• From Pathogenesis to Treatment—New Perspectives in Rheumatology 2.0 (Deadline: 31 October 2023)
• Molecular Pathophysiology of Mineralized Tissues (Deadline: 31 October 2023)
• Heartfulness: Contributors of Healthy and Unhealthy Cardiac Aging (Deadline: 31 October 2023)
• Mucopolysaccharidoses: Diagnosis, Treatment and Management 4.0 (Deadline: 31 October 2023)
• Research Advances in Emerging Infectious Diseases (Deadline: 31 October 2023)
• Signalling Pathway and Regulation of Oxidative Stress in Lung Diseases (Deadline: 31 October 2023)
• Exploring Molecular Mechanisms of Liver Fibrosis (Deadline: 31 October 2023)
• The Biology and Clinical Implementation of Circulating Tumor Cells in Cancer Metastasis (Deadline: 31 October 2023)
• The Molecular Basis of Extracellular Vesicles in Health and Diseases (Deadline: 31 October 2023)
• In Honor of Elie Metchnikoff, a Nobel Prize Winner, Who Discovered Macrophages as Phagocyte Cells Involved in the Process of Innate Immunity (Deadline: 31 October 2023)
• Ischemic Retinal Diseases: Pathophysiology, Retinal Imaging and Therapeutics (Deadline: 31 October 2023)
• The Pathogenesis and Therapy of Endometriosis (Deadline: 31 October 2023)
• Exposome and Mechanisms of Brain Pathology: From Single Cell to Cerebral Networks and Behavior (Deadline: 31 October 2023)
• Molecular Research in Heart Disease (Deadline: 31 October 2023)
• Advanced Therapies for Inherited Diseases and Cancer: Recent Progress (Deadline: 31 October 2023)
• Molecular Mechanisms of Myocardial Injury and Repair (Deadline: 31 October 2023)
• Genetic and Epigenetic Control of Disease Occurrence (Deadline: 31 October 2023)
• Dermatology: Advances on Pathophysiology and Therapies (Deadline: 31 October 2023)
• New Insights into Coronary Vascular Pathophysiology: Gateways to Improved Therapies? (Deadline: 1 November 2023)
• Advances on Retinal Diseases (Deadline: 15 November 2023)
• Mitochondria-Mediated Oxidative Stress in Diseases: Cell Death and Treatment (Deadline: 15 November 2023)
• New Technologies and Approaches for Skin Disease Treatment (Deadline: 15 November 2023)
• Digestive Inflammation and New Therapeutical Targets (Deadline: 15 November 2023)
• Key Advances in Cardiovascular Diseases (Deadline: 15 November 2023)
• Bridging the Gap: Exploring the Link between Metabolic Disorders and Musculoskeletal Diseases (Deadline: 15 November 2023)
• Recent Advances in Endometriosis Pathophysiology and Pharmacological Treatment (Deadline: 15 November 2023)
• Essential Metals in Neurological Diseases and Cancer (Deadline: 15 November 2023)
• Recent Advances in the Physiology of Ion Channels in Sperm Cells (Deadline: 15 November 2023)
• Recent Advances of Biochemistry and Molecular Biology of Infectious Diseases, 2nd Edition (Deadline: 15 November 2023)
• Aquaporins in Brain Disease (Deadline: 15 November 2023)
• Modern Strategies for Diagnosis and Treatment of Parasitic Diseases (Deadline: 15 November 2023)
• Acute Radiation Syndrome and Therapies after Combined Radiation Injury (Deadline: 15 November 2023)
• The Role of Tyrosinase in Human Health and Disease (Deadline: 15 November 2023)
• Molecular Research in Inflammatory Bowel Disease (Deadline: 20 November 2023)
• Role of NLRP3 in Inflammation and Tumour (Deadline: 20 November 2023)
• FLASH Radiotherapy: From Benchwork to a New Paradigm-Shifting Radiotherapy (Deadline: 20 November 2023)
• Inflammation in Skin and Joints (Deadline: 20 November 2023)
• Hematological Malignancies: Molecular Mechanisms and Therapy (Deadline: 25 November 2023)
• Advances in Lung Injury, Regeneration, and Fibrosis (Deadline: 25 November 2023)
• Recent Advances on Multi-Target Directed Ligands (Deadline: 25 November 2023)
• Recent Advances in the Molecular Biology of Organ Transplantation (Deadline: 25 November 2023)
• Research on Mass Spectrometry Techniques for Biomarker and Proteomics Analysis (Deadline: 25 November 2023)
• Recent Molecular Research in Virology and Oncology (Deadline: 25 November 2023)
• Advances in Lung Inflammation, Injury, and Repair (Deadline: 25 November 2023)
• Hunting for Prospective Molecular Approaches to Prevent Cardiac Arrhythmias (Deadline: 29 November 2023)
• Liver Tissue Damage and Repair (Deadline: 29 November 2023)
• Mitochondrial Diseases: Pathophysiological Mechanisms and Treatment Strategies (Deadline: 29 November 2023)
• Innate and Innate-Like Lymphoid Cells: New Populations and Old Tricks (Deadline: 29 November 2023)
• Molecular Insight into Zoonotic Infections (Deadline: 29 November 2023)
• Inflammation and Diseases during Pregnancy: From Pathogenic Mechanisms to Therapy (Deadline: 29 November 2023)
• Molecular Mechanism of Retinal Diseases: New Insights (Deadline: 29 November 2023)
• Molecular Mechanisms of Cardiovascular Disease 2023 (Deadline: 29 November 2023)
• Serotonin Receptors in Human Health and Disease (Deadline: 29 November 2023)
• Dyslipidemia and Related Diseases (Deadline: 29 November 2023)
• Recent Progress in Regenerative Therapy Using Blood-Derived Biomaterials (Deadline: 29 November 2023)
• Novel Targeted Therapies and Drugs in Cancer (Deadline: 29 November 2023)
• Whole-Cell System and Synthetic Biology (Deadline: 30 November 2023)
• 55th Anniversary of IgE Discovery: Pros and Cons of Anti-IgE Treatment (Deadline: 30 November 2023)
• Colorectal Cancer: From Molecular Pathology to Therapeutics (Deadline: 30 November 2023)
• Metabolism-Induced Oxidative Stress and DNA Damage in Human Diseases (Deadline: 30 November 2023)
• Advanced Progress and Application of Photodynamic Therapy (Deadline: 30 November 2023)
• Scientific Discoveries Supporting Theories in Science: From Thinking to Practice 2.0 (Deadline: 30 November 2023)
• Molecular Mechanisms Related to Burns, Burn Wound Healing and Scarring 3.0 (Deadline: 30 November 2023)
• Polycystic Ovary Syndrome: From Molecular Mechanisms to Therapies 3.0 (Deadline: 30 November 2023)
• The Role of Aminotransferase in Human Health and Disease (Deadline: 30 November 2023)
• Pathology of Gliomas (Deadline: 30 November 2023)
• Probing the Role of Metabolomics to Unveil the Molecular Landscape of Cardiovascular Diseases (Deadline: 30 November 2023)
• Sepsis: Molecular Research (Deadline: 30 November 2023)
• Molecular Mechanisms of Retinal Diseases: An Update (Deadline: 30 November 2023)
• Molecular Advances in Liver Fibrosis (Deadline: 30 November 2023)
• Molecular Research of Hepatocellular Carcinoma (Deadline: 30 November 2023)
• New Insights into Periodontitis: From Biology to Treatment (Deadline: 30 November 2023)
• Molecular Pathology, Diagnostics and Therapeutics of Nephropathy 3.0 (Deadline: 30 November 2023)
• Exploring Molecular Mechanisms of Inflammatory Diseases (Deadline: 30 November 2023)
• Blood-Brain Barrier and Blood-Retinal Barrier Diseases: Molecular Mechanisms, Patterns, and New Concepts (Deadline: 30 November 2023)
• Genetic Advances in Gastrointestinal Diseases (Deadline: 30 November 2023)
• Targeting Collagen-Related Therapy (Deadline: 30 November 2023)
• Advancements in Molecular Research on Infertility (Deadline: 30 November 2023)
• Molecular Diagnostics and Therapeutic Target in Bladder Cancer (Deadline: 30 November 2023)
• New Horizons for Investigating Respiratory Diseases: Inflammation and Repair (Deadline: 30 November 2023)
• Molecular Research of Biomedical X-ray Fluorescence Imaging (XFI) (Deadline: 30 November 2023)
• New Insights into Treatment of Chronic Obstructive Pulmonary Disease (Deadline: 30 November 2023)
• Protein Aggregation: From Molecular Biology to Human Disease (Deadline: 30 November 2023)
• Molecular Advances in Peritoneal Dialysis (Deadline: 30 November 2023)
• Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases (Deadline: 30 November 2023)
• Molecular Mechanisms of Retinal Diseases and Degeneration (Deadline: 30 November 2023)
• Molecular Pathogenesis and Therapeutics in Viral Hepatitis (Deadline: 30 November 2023)
• Diabetes and Its Complications: From Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 30 November 2023)
• Molecular Advances in New Combination Therapies for Cancer (Deadline: 30 November 2023)
• Unraveling the Molecular Impact of Sex and Gender on Disease Progression: An In-Depth Exploration (Deadline: 30 November 2023)
• Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment 2.0 (Deadline: 30 November 2023)
• Targeting Corneal Wound Healing: Molecular Access to Diagnosis, Pathophysiology, and Treatment (Deadline: 30 November 2023)
• METTL-Family Enzymes in Human Health and Diseases (Deadline: 30 November 2023)
• Osteoporosis: From Molecular Mechanisms to Therapies 4.0 (Deadline: 30 November 2023)
• Role of Drosophila in Human Disease Research 4.0 (Deadline: 30 November 2023)
• Recent Molecular Advances in the Immunopathology of Bone Disease (Deadline: 30 November 2023)
• Lymphatic System in Vascular Disease (Deadline: 30 November 2023)
• Focus on Cartilage Biology (Deadline: 30 November 2023)
• Molecular Diagnostic and Therapeutic Advances of Type 2 Diabetes and Its Complications (Deadline: 30 November 2023)
• Transcription Factors in Lung Cancer: Mechanisms and Future Perspectives (Deadline: 30 November 2023)
• Molecular Mechanisms and Therapeutic Strategies of Inflammatory Pain (Deadline: 30 November 2023)
• Physiology and Pathophysiology of Placenta (Deadline: 30 November 2023)
• Recent Advances in Photobiomodulation Therapy (PBMT) (Deadline: 30 November 2023)
• Molecular Research on Inherited Metabolic Disorders 2.0 (Deadline: 30 November 2023)
• Retinal Degenerative Diseases 2.0 (Deadline: 30 November 2023)
• Molecular Advances in Orthopedic Trauma and Therapy (Deadline: 30 November 2023)
• Rare Diseases: A Diagnostic and Therapeutic Challenge (Deadline: 30 November 2023)
• Dry Eye and Ocular Surface Disorders 5.0 (Deadline: 30 November 2023)
• Immunotherapy-Based Combinations in Thoracic Malignancies (Deadline: 30 November 2023)
• Molecular Advances and Therapeutic Strategies in Renal Failure (Deadline: 30 November 2023)
• The Endocannabinoid System: New Insights into Its Role in Health and Disease (Deadline: 30 November 2023)
• Recent Molecular Biology on Ovarian Cancer and Prostate Cancer (Deadline: 30 November 2023)
• Recent Advancements in Organ Transplantation: From Organ Protection to Molecular Therapy (Deadline: 30 November 2023)
• New Molecular Biology and Perspective: Heart Failure (Deadline: 30 November 2023)
• 10th Anniversary of the Institute of Fundamental Medicine and Biology, Kazan Federal University (Deadline: 30 November 2023)
• Molecular Mechanisms of Human Liver Diseases 2.0 (Deadline: 30 November 2023)
• Molecular Research on Autophagy (Deadline: 30 November 2023)
• Chronic Pain and Fibromyalgia: Biomarkers and Pathophysiology (Deadline: 30 November 2023)
• Advanced Molecular Research in Lung Diseases (Deadline: 30 November 2023)
• Recent Advances in Cystic Fibrosis: Pathophysiology, Molecular Mechanisms and Novel Therapies (Deadline: 30 November 2023)
• Contribution of Dysfunctional Microvasculature to Cardiovascular Diseases (Deadline: 30 November 2023)
• Non-coding RNAs' Functionality-Diagnosis and Therapy in Cancer and Other Indications (Deadline: 30 November 2023)
• New Molecule Therapy for Lung Cancer: MicroRNA (Deadline: 30 November 2023)
• Genetics and Epigenetics in the Pathology, Diagnosis and Therapeutics of Cardiovascular Diseases (Deadline: 30 November 2023)
• New Insights into Oxidative Stress and Inflammation in Chronic Diseases (Deadline: 30 November 2023)
• Epigenetic Mediators Inducing Pathophysiological Changes in Cardiac Diseases (Deadline: 30 November 2023)
• Natural Products and Hepatic Health: Lights and Shadows (Deadline: 30 November 2023)
• Research on Mitochondria and Cell Death in Disease Diagnosis and Treatment (Deadline: 5 December 2023)
• Molecular and Cellular Research in Pregnancy-Related Complications (Deadline: 15 December 2023)
• Infectious Diseases: Focus on Molecular Mechanisms and Future Therapy (Deadline: 15 December 2023)
• Advances in Molecular Research on Autoimmune Diseases (Deadline: 15 December 2023)
• Human and Animal Monocytes and Macrophages in Homeostasis and Disease 5.0 (Deadline: 15 December 2023)
• Adipose Tissue Dynamics in Laminopathies (Deadline: 15 December 2023)
• Molecular Mechanisms of Uterine Receptivity for Embryo Implantation (Deadline: 15 December 2023)
• Functional Molecules in Tracing and Cancer Therapeutics (Deadline: 15 December 2023)
• Heart-Brain Interaction: Atrial Fibrillation and Stroke (Deadline: 15 December 2023)
• Molecule Research in Normal and Pathological Brain Aging (Deadline: 15 December 2023)
• Pathophysiological and Molecular Signaling Impacts of Chronic Hypoxia and Intermittent Hypoxia (Deadline: 15 December 2023)
• Gastrointestinal Diseases: Molecular Mechanism, Diagnostics, and Novel Therapeutic Approaches (Deadline: 15 December 2023)
• New Challenges of Parkinson’s Disease (Deadline: 15 December 2023)
• Molecular Research on Diabetic Wound Healing (Deadline: 15 December 2023)
• Cellular and Molecular Mechanisms in the Developmental Origins of Health and Disease (Deadline: 20 December 2023)
• Non-coding RNAs in Tumor Development and Angiogenesis (Deadline: 20 December 2023)
• Autoimmune and Autoinflammatory Disorders: Current Issue and Future Perspectives (Deadline: 20 December 2023)
• Epilepsy: Molecular Mechanisms and Therapies (Deadline: 20 December 2023)
• Pulmonary Hypertension: Pre-clinical Research on New Molecular Targets and Therapeutic Strategies (Deadline: 20 December 2023)
• Sarcomere Function in Health and Disease 2.0: New Insights from Traditional to Advanced Animal-Free Studies (Deadline: 20 December 2023)
• Molecular Physiological and Pathological Progression of Neurological Diseases (Deadline: 20 December 2023)
• New Biomarkers and Therapy for Cancer Stem Cells (Deadline: 20 December 2023)
• Heparin, Heparan Sulfate and Heparanase in Health and Disease (Deadline: 20 December 2023)
• Molecular Pathways in Myocardial Dysfunction and Cardioprotection (Deadline: 20 December 2023)
• Application of Natural Products in Prevention of Bone Related Diseases (Deadline: 22 December 2023)
• Molecular Research on Skeletal Muscle Diseases (Deadline: 25 December 2023)
• Molecular Insights into Pathogenesis and Therapy of Muscular Dystrophies (Deadline: 25 December 2023)
• Zebrafish as a Model in Human Disease 2.0 (Deadline: 28 December 2023)
• Current Molecular Progress on Cell and Gene Therapies (Deadline: 28 December 2023)
• Sustainable Approaches in Skin Conditions 2.0 (Deadline: 28 December 2023)
• Age-Related Macular Degeneration and Diabetic Retinopathy (Deadline: 28 December 2023)
• Immune Evasion and Pathological Prognostic Biomarkers in Bladder Cancer (Deadline: 29 December 2023)
• Inflammatory Bowel Disease’s Journey: From Metabolism and Immunity to New Therapeutic Horizons (Deadline: 29 December 2023)
• Discovery of Bioactive Compounds That Control Osteoblast/Osteoclast Differentiation (Deadline: 29 December 2023)
• miRNA-Mediated Post-transcriptional Regulation in the Nervous System (Deadline: 30 December 2023)
• Advances in Mycobacterial Diagnostics and Therapy (Deadline: 30 December 2023)
• Novel Diagnostic and Preventive Options of Pregnancy Complications Originated from Placental Pathologies (Deadline: 30 December 2023)
• Insights into Mechanisms Underlying Cardiovascular Disease (Deadline: 30 December 2023)
• Gynecological Cancer: Targeted Therapeutics and Future Perspectives (Deadline: 30 December 2023)
• Molecular Mechanisms of Placental Diseases and Related Pregnancy Complications (Deadline: 30 December 2023)
• Novel Research Targeting Cancer Metabolism: Development and Updates (Deadline: 30 December 2023)
• Advances in Inflammasomes in the Post-pandemic Era (Deadline: 30 December 2023)
• Pathophysiology and Novel Therapeutic Strategies of Neurological Diseases (Deadline: 30 December 2023)
• Atherosclerosis: From Molecular Biology to Therapeutic Perspective 5.0 (Deadline: 30 December 2023)
• Hypertension and Dyslipidemia: From Pathogenesis to Therapeutic Perspective (Deadline: 30 December 2023)
• Molecular Mechanisms of Musculoskeletal Involvement in Rare Diseases (Deadline: 30 December 2023)
• New Pathogenic Mechanism of Proteases in Inflammatory Lung Diseases (Deadline: 30 December 2023)
• Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia 3.0 (Deadline: 30 December 2023)
• Molecular Mechanism in Multiple Sclerosis and Related Disorders (Deadline: 30 December 2023)
• The Epigenetic Landscape in Cancer (Deadline: 30 December 2023)
• Growth Hormone Deficiency: Molecular Pathologies and Therapeutic Strategies (Deadline: 30 December 2023)
• Schizophrenia: From Molecular Mechanism to Therapy (Deadline: 30 December 2023)
• The Role of Natural and Synthetic Sulfur Compounds in Human Health and Diseases (Deadline: 30 December 2023)
• Pathophysiologic Mechanisms of Eye Diseases and Novel Therapeutic Approaches 2.0 (Deadline: 30 December 2023)
• Neuroinflammation in Neurodegenerative Diseases – a Target for Novel CNS-Permeable Anti-inflammatory Drugs? (Deadline: 30 December 2023)
• Molecular Therapy for Heart Failure (Deadline: 30 December 2023)
• Bioactive Lipids and Their Derivatives in Biomedical Applications (Deadline: 30 December 2023)
• Advances of Molecular Research in Reproductive Endocrinology (Deadline: 30 December 2023)
• Highlights in Pathophysiology of the Musculoskeletal System 2.0 (Deadline: 30 December 2023)
• Molecular Pathology, Diagnostics, and Therapeutics of Kidney Disease (Deadline: 30 December 2023)
• Looking into the Skin in Health and Disease: From Microscopy Imaging Techniques to Molecular Analysis 2.0 (Deadline: 30 December 2023)
• The Zebrafish Model in Animal and Human Health Research (Deadline: 31 December 2023)
• New Technologies and Applications in Proteomics Research (Deadline: 31 December 2023)
• Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment (Deadline: 31 December 2023)
• Translational Medicine of Vascular and Lymphatic Diseases: From the Molecule to the Clinic (Deadline: 31 December 2023)
• Jaw Bone Disorders—Temporomandibular Joint Disorders, Periodontal Pathology and Others (Deadline: 31 December 2023)
• Age-Related Vascular Physiology (Deadline: 31 December 2023)
• Advances and Insights in Treatment of Endometriosis, Uterine Fibroids and Other Benign Gynecologic Diseases (Deadline: 31 December 2023)
• Recent Advances in Alcohol-Related Liver Diseases (Deadline: 31 December 2023)
• Lipid Mediated Mechanisms in Neurologic and Neuropsychiatric Disease (Deadline: 31 December 2023)
• Transglutaminase 2 and Cellular Functions (Deadline: 31 December 2023)
• Molecular and Translational Research in Cardiovascular Endocrinology, Cardio-Metabolic Diseases and Non-alcoholic Fatty Liver Disease (NAFLD) (Deadline: 31 December 2023)
• Hydrogen Sulfide and H₂S Donors in Cardiovascular, Metabolic, and Inflammatory Diseases (Deadline: 31 December 2023)
• Angiogenic and Pathological Performance of Vascular Endothelial Cells (Deadline: 31 December 2023)
• Extracellular Vesicles in Microbes, Pathogens and Infectious Diseases 2.0 (Deadline: 31 December 2023)
• Comprehensive Insights into Molecular Mechanisms and Pathophysiology of Spinal Cord Injury (Deadline: 31 December 2023)
• Advances in Research on Craniofacial Biology and Dentistry 2.0 (Deadline: 31 December 2023)
• New Perspectives in Hematopoietic Stem Cell and Leukemia (Deadline: 31 December 2023)
• Recent Advances in Skeletal Muscle Physiology and Pathophysiology (Deadline: 31 December 2023)
• Pathophysiology of Acute Kidney Injury (Deadline: 31 December 2023)
• The Role of Astrocytes in Human Diseases (Deadline: 31 December 2023)
• The Role of Extracellular Matrix Proteins in Pathogenesis (Deadline: 31 December 2023)
• Molecular Advances in Gut Microbiota and Intestinal Diseases (Deadline: 31 December 2023)
• Neural Processes in the Tumor Microenvironment (Deadline: 31 December 2023)
• Molecular Mechanisms and Pathophysiology of Myocardial Disease (Deadline: 31 December 2023)
• The Burden of Ectopic Calcification: An Integrated Understanding of Genetic, Molecular and Pathophysiological Aspects (Deadline: 31 December 2023)
• Hepatopancreatic and Intestine Diseases: From Molecular Basis to Therapy (Deadline: 31 December 2023)
• Pharmacological Approaches and Models of Physical Activity in the Treatment of Inflammatory Diseases and Cancer (Deadline: 31 December 2023)
• C. elegans as a Disease Model: Molecular Perspectives (Deadline: 31 December 2023)
• Innovative Radiation Therapies (Deadline: 31 December 2023)
• Molecular Epidemiology of Vector-Borne Pathogens (Deadline: 31 December 2023)
• Anemia and Iron Metabolism: Laboratory Diagnosis, Novel Biomarkers and Environmental Influence (Deadline: 31 December 2023)
• Molecular Advances and Perspectives of Lung Disease (Deadline: 31 December 2023)
• Towards an Understanding of Retinal Diseases and Novel Treatment 3.0 (Deadline: 31 December 2023)
• Molecular Insight into Retinal Diseases (Deadline: 31 December 2023)
• Understanding the Role of Non-coding DNA in Neurodegenerative Disease (Deadline: 31 December 2023)
• Advances in Cardiovascular Remodeling (Deadline: 31 December 2023)
• Molecular and Cellular Mechanisms of Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases 2.0 (Deadline: 31 December 2023)
• Molecular Pathogenesis and Therapies for Retinal and Optic Nerve Diseases (Deadline: 31 December 2023)
• Melanosome Transport/Transfer and Melanin Pigmentation in the Skin 2.0 (Deadline: 31 December 2023)
• Molecular and CelluIar Mechanisms of Valvular Heart Disease (Deadline: 31 December 2023)
• Regulatory Mechanisms of Ion Channels and Their Potential as Therapeutic Targets 2.0 (Deadline: 31 December 2023)
• Novel Research of Neuroinflammation in the Pathogenesis of Alzheimer's Disease and Related Dementias (Deadline: 31 December 2023)
• Oxidative Stress and Inflammation in Cardiovascular Disease (Deadline: 31 December 2023)
• New Molecular Progression of Neuro-Orthopaedics (Deadline: 31 December 2023)
• New Molecular Therapeutic Approaches for Cystic Fibrosis (Deadline: 31 December 2023)
• The Human Fetal Membranes: A Versatile Tissue Important for Pregnancy Health and Regenerative Therapies (Deadline: 31 December 2023)
• Recent Perspectives on Oxidative Stress, Metabolic and Inflammatory Diseases (Deadline: 31 December 2023)
• Recent Molecular Research on Preeclampsia (Deadline: 31 December 2023)
• New Strategies for the Diagnosis and Treatment of Diseases Caused by Parasites (Deadline: 31 December 2023)
• Biosensors for the Early Diagnosis of High-Impact Human Diseases (Deadline: 31 December 2023)
• Novel Insights into the Molecular Mechanisms of Atherosclerosis and Vascular Calcification (Deadline: 31 December 2023)
• Diseases of the Eye and Adnexa: From Cellular and Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 31 December 2023)
• New Therapeutic Strategies for Lymphoma (Deadline: 31 December 2023)
• Immunological Approaches in Tumor Therapy 2.0 (Deadline: 31 December 2023)
• Rare Diseases and Neuroscience (Deadline: 31 December 2023)
• Advances in Molecular Research and Treatment of Asthma (Deadline: 31 December 2023)
• Cytokines: From Cancer to Autoimmunity 2.0 (Deadline: 31 December 2023)
• Molecular Mechanisms of Sjögren's Syndrome 3.0 (Deadline: 31 December 2023)
• Placenta-Brain Communication in Normal and Pathological Pregnancies (Deadline: 31 December 2023)
• Advances in Molecular Research on Neuroprotective Approaches to Stroke (Deadline: 31 December 2023)
• New Insights into the Use of Mouse Models for the Study of Musculoskeletal Diseases (Deadline: 31 December 2023)
• New Therapy for Breast Cancer (Deadline: 31 December 2023)
• Molecular Pathogenesis of Depression and Therapeutic Mechanisms of Antidepressant Effects (Deadline: 31 December 2023)
• Transcriptional Therapy and Nucleic Acid-Based Therapeutics: From Molecular Targets to Preclinical Studies 2.0 (Deadline: 31 December 2023)
• Metabolic Mechanisms of Cardiac Injury (Deadline: 31 December 2023)
• Kidney Diseases: From Molecular Basis to Therapy (Deadline: 31 December 2023)
• Roles of Non-coding RNAs in Diseases (Deadline: 31 December 2023)
• Mechanisms and Therapeutic Opportunities of Sphingolipids: Where Are We? (Deadline: 31 December 2023)
• Genetics, Epigenetics, Proteomics and Functional Genomic Approaches in Infectious Diseases (Deadline: 31 December 2023)
• The Role of Protease Inhibitors in Infectious Diseases (Deadline: 31 December 2023)
• Molecular and Pathophysiological Mechanisms of Peritoneal Fibrosis in Peritoneal Dialysis (Deadline: 31 December 2023)
• Pregnancy Complicated by Hypertension—New Horizons in the Pathomechanism, Diagnosis, and Treatment (Deadline: 31 December 2023)
• Molecular Mechanisms of Retinal Degeneration and How to Avoid It 2.0 (Deadline: 31 December 2023)
• The Role of Protease and Protease Inhibitors in Human Diseases (Deadline: 31 December 2023)
• Drug Therapies for Diabetes (Deadline: 31 December 2023)
• Liver-Gut Axis 3.0 (Deadline: 31 December 2023)
• Glaucoma: Diagnostics and Therapeutic Perspectives (Deadline: 31 December 2023)
• Lipoprotein(a) and Cardiovascular Diseases (Deadline: 1 January 2024)
• Advances in Magnetic Resonance Imaging in Diagnostics (Deadline: 1 January 2024)
• Molecular Advances in Glomerular Diseases (Deadline: 1 January 2024)
• Hepatocellular Carcinoma in 2023: What Is New on Pathogenesis, Diagnosis and Treatment (Deadline: 1 January 2024)
• Molecular Advances in Liver Inflammation and Fibrosis (Deadline: 10 January 2024)
• Virus and Cancers: Association with the Disease and Therapies (Deadline: 15 January 2024)
• Insights into Oral Squamous Cell Carcinoma (Deadline: 15 January 2024)
• Molecular Landscape of Cutaneous Wound Healing in Health and Disease (Deadline: 15 January 2024)
• New Discoveries in Cartilage Biology (Deadline: 15 January 2024)
• Molecular Pathophysiology of Lung Diseases (Deadline: 15 January 2024)
• Interrelation between Heart Failure and Chronic Kidney Disease: A Focus on Molecule Mechanisms (Deadline: 15 January 2024)
• Genetics, Genomics and Molecular Pathogenesis of Myocardial Diseases (Deadline: 15 January 2024)
• Identification of New Molecular Subgroups in Breast Cancer (Deadline: 15 January 2024)
• The Role of Specific Alteration in Neurological Disorders: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 20 January 2024)
• New Advance on Molecular Targets for the Treatment of Pain (Deadline: 20 January 2024)
• Breast Cancer: Molecular Pathology, Diagnosis, and Therapeutic Strategies (Deadline: 20 January 2024)
• Recent Advances in the Diagnosis and Treatment of Chronic Liver Diseases 2023 (Deadline: 20 January 2024)
• Molecular Research on Systemic Sclerosis: From Pathogenesis to Management (Deadline: 20 January 2024)
• Vasculitis: From Molecular Biology to Therapy (Deadline: 20 January 2024)
• Ovarian Dysfunction, Infertility and Its Treatment (Deadline: 20 January 2024)
• Cellular and Molecular Mechanisms of Blood–Brain Barrier Dysfunction 3.0 (Deadline: 20 January 2024)
• Recent Developments and Updates in Acute Lymphoblastic Leukemia (Deadline: 20 January 2024)
• Molecular Pathology and Immunotherapy of Lymphoma (Deadline: 25 January 2024)
• Functional Defects of Keratinocytes in Inflammatory Skin Diseases 2.0 (Deadline: 25 January 2024)
• Omics Sciences for Salivary Diagnostics (Deadline: 25 January 2024)
• New Biological and Immunological Approaches to Cancer Therapy (Deadline: 28 January 2024)
• Advances in Molecular and Translational Medicine 2.0 (Deadline: 28 January 2024)
• Advances in Prostate Cancer Diagnostics and Therapy (Deadline: 29 January 2024)
• Neurodegeneration: From Genetics to Molecules 2.0 (Deadline: 29 January 2024)
• Genetic and Molecular Advances in Glaucoma (Deadline: 30 January 2024)
• Cardiovascular Diseases: Molecular Mechanisms, Biomarkers, and Therapies (Deadline: 30 January 2024)
• Retinal Diseases: From Molecular Pathology to Therapies (Deadline: 30 January 2024)
• Molecular Pathogenesis of Intervertebral Disc Disease (Deadline: 30 January 2024)
• Emerging Concepts in Neurodegeneration Research (Deadline: 30 January 2024)
• Molecular Relationships between Brain and Lung Diseases (Deadline: 30 January 2024)
• Smooth Muscle Cells in Vascular Disease (Deadline: 30 January 2024)
• Molecular Advances in Haematological Malignancies (Deadline: 30 January 2024)
• Environmental Pollutants and Lung Diseases: Cellular and Molecular Mechanisms (Deadline: 30 January 2024)
• Advances in Therapeutics against Eukaryotic Pathogens (Deadline: 30 January 2024)
• Molecular Advances in Retinal Diseases (Deadline: 30 January 2024)
• Aging and Chronic Kidney Disease (Deadline: 30 January 2024)
• New Advances in Thrombosis 2.0 (Deadline: 30 January 2024)
• Endothelial Dysfunction and Cardiovascular Diseases (Deadline: 30 January 2024)
• Advanced Research on Wound Healing 2.0 (Deadline: 30 January 2024)
• Targeting Breast Cancer: Strategies and Hope 2.0 (Deadline: 30 January 2024)
• Cardiovascular Diseases: Histopathological and Molecular Diagnostics (Deadline: 30 January 2024)
• Molecular Basis and Treatment of Skin Diseases and Their Associated Complications (Deadline: 30 January 2024)
• Exosomes and Extracellular Vesicles in Health and Diseases 2.0 (Deadline: 30 January 2024)
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology (Deadline: 30 January 2024)
• Atherosclerosis 2.0: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 January 2024)
• Molecular Diagnostics and Therapeutics of Epileptic Neurodevelopment (Deadline: 30 January 2024)
• Molecular Basis and Therapy of Optic Neuropathies (Deadline: 31 January 2024)
• New Advances in Proteomics in Disease (Deadline: 31 January 2024)
• Autoimmunity Disease and Viral Infections (Deadline: 31 January 2024)
• Heart Failure Mechanisms and Treatment Advances (Deadline: 31 January 2024)
• Advanced Research of Skin Inflammation and Related Diseases (Deadline: 31 January 2024)
• Role of Mitochondria in Diseases (Deadline: 31 January 2024)
• Sodium Channel in Cardiovascular Diseases and Health (Deadline: 31 January 2024)
• Molecular Advances in Ageing-Related Cardiovascular Diseases (Deadline: 31 January 2024)
• Molecular Research in Gynecological Diseases (Deadline: 31 January 2024)
• Molecular Insights in Zebrafish Models: Muscular Dystrophy and Mitochondrial Metabolism (Deadline: 31 January 2024)
• Ischemia Reperfusion Injury: A Cell Signaling Crossroads and Therapeutics (Deadline: 31 January 2024)
• Molecular Insights into the Developmental Origins of Health and Disease (Deadline: 31 January 2024)
• Liver Diseases: From Molecular Basis to Potential Therapy (Deadline: 31 January 2024)
• New Advances in Congenital Disorders – from Molecular Basis (Deadline: 31 January 2024)
• New Insights into Endothelial Injury (Deadline: 31 January 2024)
• Molecular Insights into Infectious Diseases (Deadline: 31 January 2024)
• Aquatic Organisms Models Dedicated to Disease (Deadline: 31 January 2024)
• Adipose Tissue Diseases: Physiopathology, Molecular Mechanism, Diagnosis and Treatment (Deadline: 31 January 2024)
• Towards in Vasculitis: Genetics and Beyond (Deadline: 31 January 2024)
• Recent Advances in Gluten-Related Disorders (Deadline: 31 January 2024)
• Cardiovascular Disease: Molecular Advances on Pathophysiology and Therapies (Deadline: 31 January 2024)
• Biomarkers’ Identification of Aging and Age-Related Pathologies (Deadline: 31 January 2024)
• Recent Progress with Duchenne Disease: From Molecular Pathology to Therapies (Deadline: 31 January 2024)
• Coronavirus Disease (COVID-19): Pathophysiology 4.0 (Deadline: 31 January 2024)
• Cystic Fibrosis and CFTR Interactions 2.0 (Deadline: 31 January 2024)
• Molecular Mechanisms and Therapies in Skeletal Muscle Diseases (Deadline: 31 January 2024)
• Molecular Research in Uterine Biology and Pathophysiology 2.0 (Deadline: 31 January 2024)
• Genetic Basis and Molecular Mechanism of Heart Failure (Deadline: 31 January 2024)
• New Challenges and Perspectives in Polycystic Ovary Syndrome (Deadline: 31 January 2024)
• Photodynamic Therapy and Photodetection, 2nd Edition (Deadline: 31 January 2024)
• Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 3.0 (Deadline: 31 January 2024)
• The Role of Antithrombin in Blood Disorders (Deadline: 31 January 2024)
• Molecular Mechanisms of Platelet-Related Disorders (Deadline: 31 January 2024)
• Molecular Research of Endocytic and Autophagic Pathways in Diseases (Deadline: 31 January 2024)
• Novel Molecular Research Targeting the Application of FFPE Tissue: Development and Updates (Deadline: 1 February 2024)
• Reproductive-Related Disorders: Molecular Pathogenesis, Diagnosis and Treatment (Deadline: 15 February 2024)
• Biomolecules in the Treatment of Biofilm-Related Diseases (Deadline: 15 February 2024)
• Exploring the Molecular, Cellular, and Physiological Basis of Hearing Disorders (Deadline: 15 February 2024)
• Molecular Advances and Insights on Diagnosis, Prevention and Therapeutics of Cardiovascular Diseases (Deadline: 15 February 2024)
• Pulmonary Fibrosis: Molecular Pathology, Diagnosis, and Therapeutic Strategies (Deadline: 15 February 2024)
• Cystic Fibrosis: Molecular Pathogenesis, Diagnosis, and Treatment (Deadline: 15 February 2024)
• Urolithiasis: From Molecular Pathology to Novel Therapeutic Approach (Deadline: 15 February 2024)
• Molecular Research on Vascular Disease: Current Status and Future Directions (Deadline: 15 February 2024)
• Recent Advances in Hypertension and Cardiovascular Disease (Deadline: 16 February 2024)
• Cardiomyopathy: From Pathologies to Therapy (Deadline: 20 February 2024)
• The Cross-Knit between Immune Cells and Thyroid Function in Autoimmune Thyroid Disorders (Deadline: 20 February 2024)
• Molecular Advances in Myocardial Fibrosis in Individuals with Obesity (Deadline: 20 February 2024)
• The Role of Lysosomal Proteases in Cancer and Infectious Diseases (Deadline: 20 February 2024)
• Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 4.0 (Deadline: 20 February 2024)
• Pathogenesis and Novel Therapeutics in Breast Cancer (Deadline: 20 February 2024)
• Chronic Viral Hepatitis and Infection-Related Cancer (Deadline: 20 February 2024)
• Kidney Diseases: Molecular Pathogenesis and Therapeutic Strategies (Deadline: 25 February 2024)
• Recent Advances and Molecular Research in Prostatic Arterial Embolization (Deadline: 25 February 2024)
• Molecular Diagnosis and Treatment of Inflammatory Bowel Disease (Deadline: 25 February 2024)
• Molecular Mechanisms and Therapies of Chronic Obstructive Pulmonary Disease (Deadline: 25 February 2024)
• Recent Advances in Skin Diseases (Deadline: 25 February 2024)
• New Applications in the Diagnosis and Therapy of Diseases 2.0 (Deadline: 26 February 2024)
• Translocator Protein (TSPO) in Drug Delivery and Imaging of Pathological Disorders 2.0 (Deadline: 28 February 2024)
• Latest Updates about Interstitial Lung Disease (Deadline: 28 February 2024)
• Nucleic Acid-Based Diagnostics for Infectious Diseases (Deadline: 28 February 2024)
• Molecular Research on Adenosine Receptors: From Cell Biology to Human Diseases (Deadline: 28 February 2024)
• Is Vesicular Therapy the Newcomer That Matters for the Medicine of Tomorrow? 2.0 (Deadline: 28 February 2024)
• Three-Dimensional Bioprinting and Gene Therapy in Osteoarthritis (Deadline: 28 February 2024)
• MAPK Signaling Cascades in Human Health and Diseases (Deadline: 28 February 2024)
• Immunotherapy in Cancer: Molecular Basis and Novel Therapeutic Approaches (Deadline: 28 February 2024)
• Cardiac Arrhythmia: Molecular Mechanisms and Therapeutic Strategies (Deadline: 28 February 2024)
• Sympathetic Nerves and Cardiovascular Diseases 2.0 (Deadline: 28 February 2024)
• Research Progress in Molecular and Cellular Therapy of Cancer (Deadline: 28 February 2024)
• Celiac Disease: Genetics, Pathogenesis and Therapy 2.0 (Deadline: 28 February 2024)
• Retinal Diseases and Macular Degeneration: Cell Biology and Molecular Genetics (Deadline: 28 February 2024)
• Mitochondria Dynamics and Metabolism in Diseases (Deadline: 28 February 2024)
• Current Research for Heart Disease Biology and Therapeutics (Deadline: 28 February 2024)
• Recent Breakthroughs in the Application of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells (Deadline: 28 February 2024)
• Molecular Research on Viral Infection and Host Immunity (Deadline: 28 February 2024)
• Pulmonary Biopsy in the Diagnosis of Different Lung Diseases (Deadline: 29 February 2024)
• Cellular and Molecular Insights into Ocular Changes Associated with Systemic Disorders and Conditions (Deadline: 29 February 2024)
• Cardiovascular and Cerebrovascular Diseases: From Pathology to Therapeutic Perspectives (Deadline: 29 February 2024)
• Athlete's Heart: From Cellular–Molecular Mechanism to Structural Anomalies (Deadline: 29 February 2024)
• Colorectal Cancers: An Update on Their Molecular Pathology and Therapy (Deadline: 29 February 2024)
• Targeting Transcription Factors of Tumor Angiogenesis and Lymphangiogenesis (Deadline: 29 February 2024)
• Muscle Atrophy: From Bench to Bedside 2.0 (Deadline: 29 February 2024)
• Physiopathology of Connective Tissue: Regenerative Perspective (Deadline: 29 February 2024)
• Antiphospholipid Syndrome: From Pathophysiology to Therapy (Deadline: 29 February 2024)
• Updates & New Concepts in Collagen 2.0 (Deadline: 29 February 2024)
• The Role of microRNA in Human Diseases 2.0 (Deadline: 29 February 2024)
• Osteoarthritis: From Pathogenesis to Treatment (Deadline: 29 February 2024)
• Oral Cancers: Molecular Basis and Treatment Targets (Deadline: 29 February 2024)
• Photodynamic Therapy as Important Tool for Biological Breakthroughs 2.0 (Deadline: 29 February 2024)
• Targeting Wnt Signaling in the Tumor Microenvironment: Emerging Therapeutic Insights (Deadline: 29 February 2024)
• Gastrointestinal: Inflammation, Immunity and Cancer Pathways (Deadline: 29 February 2024)
• Immunity, Inflammation, and Injury in the Pathogenesis and Progression of Kidney Diseases—from Bench to Bedside (Deadline: 29 February 2024)
• Protein Methyltransferases in Human Health and Diseases (Deadline: 29 February 2024)
• CDKL5 Deficiency Disorders: From Molecular Mechanisms to Therapeutics (Deadline: 29 February 2024)
• Recent Advances in Immunotherapy for Breast Cancer (Deadline: 29 February 2024)
• Heart Failure: New Horizons in its Pathomechanism and Treatment (Deadline: 29 February 2024)
• Advanced Molecular Research in Benign and Malignant Lung Disease (Deadline: 29 February 2024)
• Autophagy and Immunoregulation in Human Diseases (Deadline: 29 February 2024)
• Leukemia: Present and Future (Deadline: 29 February 2024)
• Immune Regulation in Respiratory Diseases (Deadline: 29 February 2024)
• Phenylketonuria (PKU): Molecular Advances in Pathophysiology and Therapies (Deadline: 29 February 2024)
• New Insights into CKD and Age-Related Bone and Mineral Disorders (Deadline: 29 February 2024)
• Evidence-Based Principles of Diagnosis and Management of Hypertension in Modern Era (Deadline: 29 February 2024)
• Sleep Apnea and Intermittent Hypoxia (Deadline: 29 February 2024)
• The Role of Oxidative Stress in Human Health (Deadline: 29 February 2024)
• Advanced Research in Gut Inflammation and Gut-Mediated Disorders (Deadline: 29 February 2024)
• New Advances in Neural Therapeutic Application of Mesenchymal Stem Cells (Deadline: 29 February 2024)
• Underlying Molecular Mechanisms of Corneal Disease (Deadline: 29 February 2024)
• Viral Diseases of the Respiratory System—Molecular Mechanisms and Pathogenesis 2.0 (Deadline: 29 February 2024)
• Head and Neck Cancer: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 10 March 2024)
• Molecular Research of Microbial Infection and Phage Therapy (Deadline: 15 March 2024)
• Effects of Dyslipidemia and Metabolic Syndrome on Cardiac and Vascular Dysfunction (Deadline: 15 March 2024)
• Molecular Studies in Aging: New Advances (Deadline: 15 March 2024)
• Oral and Dental Infectious Diseases: Molecular Pathology, Diagnosis and Therapy (Deadline: 15 March 2024)
• Multiple Sclerosis: The Latest Developments in Immunology and Therapy (Deadline: 15 March 2024)
• Contribution of Endothelial Dysfunction to Neurovascular and Cardiovascular Diseases (Deadline: 15 March 2024)
• Molecular Research Progress of Skin and Skin Diseases (Deadline: 15 March 2024)
• New Molecular Insights into Ischemia/Reperfusion (Deadline: 20 March 2024)
• Molecular Mechanisms and Treatment of Cardiovascular Diseases (Deadline: 20 March 2024)
• Molecular Mechanisms of Pregnancy Complications (Deadline: 25 March 2024)
• Hepatitis C Virus: Pathogenetic Mechanisms, Residual Problems after Cure and Hopes for Elimination (Deadline: 25 March 2024)
• Molecular Regulatory Mechanisms of Non-coding RNA in Cardiovascular Disease (Deadline: 25 March 2024)
• Novel Therapies for Schizophrenia: Beyond Dopamine (Deadline: 25 March 2024)
• Autophagy, Cellular Senescence and Oxidative Stress in Ageing and Age-Related Diseases (Deadline: 25 March 2024)
• Molecular Research of Ocular Pathology (Deadline: 25 March 2024)
• Pathophysiology of the Serotonin System in the Nervous System and Beyond 2.0 (Deadline: 28 March 2024)
• Regeneration for Spinal Cord Disease: From Pathological Mechanisms to Novel Therapeutic Approaches (Deadline: 28 March 2024)
• Latest Progress in Messenger RNA Therapeutics (Deadline: 28 March 2024)
• 300 Years of the University of Burgundy, France—Focus on Three Health Research Themes: Neurodegenerative Diseases/Brain Function, Cardiovascular Diseases, and Cancer (Deadline: 29 March 2024)
• Chronic Inflammation: Pathophysiological Process and Nutritional Interventions (Deadline: 29 March 2024)
• Molecular Frontiers in Congenital and Adult Cardiac Surgery: From Genes to Grafts (Deadline: 30 March 2024)
• Epigenetic Biomarkers—Technologies and Applications in Complex Disease Diagnostics and Beyond (Deadline: 30 March 2024)
• Molecular Research in Vascular Disease (Deadline: 30 March 2024)
• Molecular Insight into Gestational Diabetes Mellitus (Deadline: 30 March 2024)
• Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 4.0 (Deadline: 30 March 2024)
• Advances in the Pathogenesis of Diabetic Kidney Disease: Second Edition (Deadline: 31 March 2024)
• Regeneration for Spinal Diseases 4.0 (Deadline: 31 March 2024)
• Molecular Research on Inflammatory Diseases of the Gut in Humans and Animals (Deadline: 31 March 2024)
• Etiology and Research Progress of Chronic Kidney Disease (Deadline: 31 March 2024)
• Molecular Advances in Oncologic Photodynamic Therapy (Deadline: 31 March 2024)
• Molecular Approaches for Detection and Treatment of Organ Hypoxia (Deadline: 31 March 2024)
• The Molecular and Cellular Mechanisms of Neurodegenerative Diseases 2.0 (Deadline: 31 March 2024)
• Advances in Coagulation and Anticoagulation (Deadline: 31 March 2024)
• Molecular Mechanisms of Retina Degeneration (Deadline: 31 March 2024)
• Arteriogenesis, Angiogenesis and Vascular Remodeling 2.0 (Deadline: 31 March 2024)
• Unravelling Interactions between Amyloid Beta (Aβ) and Key Pathological Features of Alzheimer’s Disease (Deadline: 31 March 2024)
• Molecular Advances in Obstetrical and Gynaecological Disorders (Deadline: 31 March 2024)
• Applications of Medical Imaging Technology in Molecular Pathological Mechanisms and Disease Therapies (Deadline: 31 March 2024)
• Vascular Changes in Systemic Degenerative Diseases and Their Pathological Implications: Molecular Biological Insights (Deadline: 31 March 2024)
• Heart Failure: From Molecular Insights to Future Treatments (Deadline: 31 March 2024)
• Molecular Insights into Thrombosis (Deadline: 31 March 2024)
• Novel Advances on Systemic Lupus Erythematosus and Antiphospholipid Syndrome (Deadline: 31 March 2024)
• Emerging Molecular Concepts in Fibroid Pathogenesis (Deadline: 31 March 2024)
• The Relevance of Lipid Metabolism in Viral Hepatitis and Hepatocellular Carcinoma (Deadline: 31 March 2024)
• Molecular Research and Insights into COVID-19 (Deadline: 31 March 2024)
• Short and Long-Term Profound Acid Inhibition: Indications and Concerns (Deadline: 31 March 2024)
• Molecular and Vascular Biology: From Pathophysiology to Therapy (Deadline: 31 March 2024)
• Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies 3.0 (Deadline: 31 March 2024)
• Exploring Molecular Interactions and Therapeutic Strategies in Cancer and Inflammation (Deadline: 31 March 2024)
• New Insights into the Molecular Mechanisms of Chronic Pain (Deadline: 31 March 2024)
• Lysosomal Storage Disorders: Pathophysiology, Molecular Mechanism and Therapeutic Strategies (Deadline: 31 March 2024)
• Molecular Advances in the Diagnosis and Drug Therapies of Atherosclerotic Cardiovascular Diseases (ASCVD) (Deadline: 31 March 2024)
• Molecular Research in Triple-Negative Breast Cancer (Deadline: 31 March 2024)
• New Insights into Kidney Diseases (Deadline: 31 March 2024)
• Cancer Diagnosis and Treatment: Exploring and Molecular Research (Deadline: 31 March 2024)
• Molecular Targeted Therapies and Precision Medicine for Malignant Diseases (Deadline: 31 March 2024)
• New Molecular Research and Perspective: Microbiota and Cancer (Deadline: 31 March 2024)
• Psoriatic Arthritis and Skin Diseases: Pathogenesis and Therapies (Deadline: 31 March 2024)
• Advanced Molecular Insights into Renal Disorders (Deadline: 31 March 2024)
• Atrial Fibrillation: From Epigenetics to Inflammatory Profile (Deadline: 31 March 2024)
• Strategies to Fight Metabolic Diseases (Deadline: 31 March 2024)
• Inflammatory Bowel Disease: Molecular Insights (Deadline: 31 March 2024)
• Etiology and Pathogenesis of Pulpitis and Apical Periodontitis 2023 (Deadline: 1 April 2024)
• New Insights into Adipose Tissue Metabolic Function and Dysfunction 2.0 (Deadline: 20 April 2024)
• Molecular Pathogenesis and Treatment of Pregnancy Complications (Deadline: 25 April 2024)
• The Role of Estrogen Receptors in Health and Diseases (Deadline: 28 April 2024)
• Obesity and Insulin Resistance: The Dark Sides of Adipose Organ Dysfunction in the Cardiometabolic Continuum (Deadline: 28 April 2024)
• Molecular Immunity and Defense: Oral and Periodontal Health (Deadline: 30 April 2024)
• Endometriosis: From Molecular Basis to Therapy (Deadline: 30 April 2024)
• New Targeted Therapies in Cancer-2023 (Deadline: 30 April 2024)
• Diabetes: From Molecular Basis to Therapy (Deadline: 30 April 2024)
• Unlocking the Future of Muscle Disease Treatment: Advancements in Gene Therapy, Antisense Therapeutics, and Cutting-Edge Pharmacological Strategies (Deadline: 30 April 2024)
• Molecular Mechanisms of Tumor-Induced Cardiac Diseases (Deadline: 30 April 2024)
• Molecular Advances in Bone Metabolism and Disorders (Deadline: 30 April 2024)
• Molecular and Cellular Mechanisms Underlying Gastrointestinal Diseases (Deadline: 30 April 2024)
• Molecular Advances in Osteoporosis Study (Deadline: 30 April 2024)
• Molecular Advance on the Pathogenesis and Treatment of Asthma (Deadline: 30 April 2024)
• Recent Advances in Molecular Mechanisms Underlying Kidney Diseases: Pathophysiology and Therapeutic Targets (Deadline: 30 April 2024)
• Molecular Insights into Atherosclerosis and Vascular Endothelial Cells (Deadline: 30 April 2024)
• Advance Research on Regenerative Medicine (Deadline: 18 May 2024)
• Mitochondrial Dysfunction: A Metabolic, Cardiovascular, Neurodegenerative and Neuromuscular Issue 2.0 (Deadline: 20 May 2024)
• Molecular Mechanisms of Pain and Analgesia (Deadline: 25 May 2024)
• Molecular Mechanisms and Novel Therapies of Liver Diseases (Deadline: 25 May 2024)
• Cutaneous Biology, Molecular Dermatology and Dermatopathology (Deadline: 31 May 2024)
• Advances in Breast and Ovarian Cancers: Pathogenetic Mechanisms, DNA Damage and Advanced Therapies (Deadline: 31 May 2024)
• Mesenchymal Stem/Stromal Cells and Hematological Diseases (Deadline: 30 June 2024)
• Advances in Anti-aging Treatment Development 2.0 (Deadline: 30 June 2024)
• Molecular Pathology and New Potential Targeted Therapies in Gastrointestinal Cancers (Deadline: 30 June 2024)
• Novel Insights into Persistent HIV Infection and Treatment (Deadline: 31 August 2024)
• New Advance on Inflammation and Repair in Respiratory Diseases (Deadline: 31 December 2024)
• Exosomes and Non-coding RNA Research in Health and Disease (Deadline: 11 June 2025)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Pathology, Diagnostics, and Therapeutics
• Immunopathology and Immunosenescence
• Molecular Understanding of the Exocrine Pancreas and Its Disorders
• Natural Products and Gut Microbiota in Age-Related Diseases
• Programmed Cell Death and Apoptosis
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in Italy (Closed)
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Head and Neck Diseases in Australia (Closed)
• State-of-the-Art Molecular Mechanisms of Hematopathology in France (Closed)
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in USA